Golenia Aleksandra, Olejnik Piotr, Maciejewska Oliwia, Wojtaszek Ewa, Żebrowski Paweł, Małyszko Jolanta
Department of Neurology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland.
J Clin Med. 2024 Oct 12;13(20):6083. doi: 10.3390/jcm13206083.
Chronic kidney disease (CKD) is a risk factor for cognitive impairment (CI), and this risk is the highest in patients with end-stage kidney disease (ESKD). As a multifactorial disease, CI may be influenced by several potentially modifiable lifestyle and behavioral factors that may reduce or increase the risk of dementia. The aim of this study was to evaluate the associations between the known modifiable risk factors for dementia and the risk of CI in patients with ESKD treated with renal replacement therapy. The Charlson Comorbidity Index and the risk of CI in patients with ESKD were also assessed. In this cross-sectional study, 225 consecutive patients with ESKD treated with different modalities of renal replacement therapy were assessed for cognitive decline using the Addenbrooke's Cognitive Examination (ACE III) test. Information was also collected on modifiable risk factors for dementia, medical history and demographics. This study included 117 patients after kidney transplantation (KT) and 108 patients with ESKD undergoing peritoneal dialysis and hemodialysis. The prevalence of modifiable risk factors for dementia differed between the groups; KT patients were more likely to be physically active, residing in cities with populations of less than 500,000 inhabitants, and were less likely to suffer from depression. Furthermore, the KT group had a lower Charlson Comorbidity Index score, indicating less severe comorbidities, and a lower risk of CI (3.6 ± 1.67 vs. 5.43 ± 2.37; = 0.001). In both the KT and dialysis groups, patients with CI were more likely to have a sedentary lifestyle (45% vs. 9%, 0.001 and 88% vs. 48%, 0.001, respectively), whereas lower educational attainment and depression had a significant negative impact on ACE III test results, but only in KT patients. Finally, cognitive function in dialysis patients was negatively affected by social isolation and living in urban areas. Modifiable risk factors for dementia, particularly a sedentary lifestyle, are associated with a higher risk of CI in patients treated with different renal replacement therapy modalities. As CI is an irreversible condition, it is important to identify lifestyle-related factors that may lead to dementia in order to improve or maintain cognitive function in patients with ESKD.
慢性肾脏病(CKD)是认知障碍(CI)的一个危险因素,这种风险在终末期肾病(ESKD)患者中最高。作为一种多因素疾病,CI可能受到几种潜在可改变的生活方式和行为因素的影响,这些因素可能会降低或增加患痴呆症的风险。本研究的目的是评估已知的痴呆症可改变风险因素与接受肾脏替代治疗的ESKD患者发生CI的风险之间的关联。还评估了Charlson合并症指数和ESKD患者发生CI的风险。在这项横断面研究中,使用Addenbrooke认知检查(ACE III)测试对225例接受不同方式肾脏替代治疗的连续ESKD患者进行了认知功能下降评估。还收集了痴呆症可改变风险因素、病史和人口统计学信息。本研究包括117例肾移植(KT)后患者和108例接受腹膜透析和血液透析的ESKD患者。痴呆症可改变风险因素的患病率在两组之间有所不同;KT患者更有可能身体活跃,居住在人口少于50万的城市,并且患抑郁症的可能性较小。此外,KT组的Charlson合并症指数得分较低,表明合并症不太严重,发生CI的风险也较低(3.6±1.67对5.43±2.37;P = 0.001)。在KT组和透析组中,发生CI的患者更有可能有久坐不动的生活方式(分别为45%对9%,P = 0.001和88%对48%,P = 0.001),而较低的教育程度和抑郁症对ACE III测试结果有显著负面影响,但仅在KT患者中如此。最后,透析患者的认知功能受到社会隔离和居住在城市地区的负面影响。痴呆症的可改变风险因素,尤其是久坐不动的生活方式,与接受不同肾脏替代治疗方式的患者发生CI的较高风险相关。由于CI是一种不可逆的病症,识别可能导致痴呆症的生活方式相关因素对于改善或维持ESKD患者的认知功能很重要。